{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:22:58Z","timestamp":1787772178721,"version":"build-2784847793"},"reference-count":94,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Primary open angle glaucoma (POAG) is a leading cause of irreversible blindness, characterized by progressive optic nerve damage often associated with elevated intraocular pressure (IOP). Treatment for POAG currently includes medical treatment, surgical intervention, or their combination. The goal of this study is to evaluate and contrast the efficacy of these several treatment methods through a systematic review and meta analysis of randomized controlled trials (RCTs) focusing on IOP reduction, visual field maintenance, and treatment related adverse effects. Studies published on POAG management were reviewed and meta analysis was done using a systematic method. Eighty RCTs in all involving patients who had either medical treatment (e.g., prostaglandin analogs, beta blockers), surgical intervention (e.g., trabeculectomy, minimally invasive glaucoma surgery), or their combination. While secondary outcomes included disease progression, quality of life, treatment satisfaction, and side effects, the primary outcomes were IOP reduction (\u226520%) and visual field progression. Regarding IOP reduction and the mean IOP reduction, the meta analysis evaluated the variations between the treatment arms. The research comprised diverse patient groups, therapy methods, and follow up periods. Although a substantial proportion of patients across medical, surgical, and combination achieved \u2265 20% IOP reduction, no statistically significant difference was observed among the groups considering IOP lowering efficacy (P = 0.5301). Surgical procedures displayed the greatest mean IOP decrease, followed by medical and combination approaches, but the difference between treatment groups was not statistically significant (P = 0.8493). Adverse effects were common across all treatments, most frequently ocular pain, hyperemia, and blurred vision. In managing POAG, this study demonstrates that medical, surgical, and combination therapies are all effective in lowering IOP and preserving visual fields. Among the therapeutic approaches, no clear superiority was identified among treatment modalities regarding mean IOP reduction. Since side effects are present among all treatments, therapy should be individualized based on patient characteristics, disease severity, and risk factors to optimize outcomes.<\/jats:p>","DOI":"10.4103\/jfmpc.jfmpc_23_26","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:00:16Z","timestamp":1781791216000},"page":"1888-1903","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Management and outcomes of primary open-angle glaucoma"],"prefix":"10.4103","volume":"15","author":[{"given":"Salem Ahmed S.","family":"Alshehri","sequence":"first","affiliation":[{"name":"Faculty of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara Ahmed S.","family":"Alshehri","sequence":"additional","affiliation":[{"name":"College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara Abdullah M.","family":"Alziyad","sequence":"additional","affiliation":[{"name":"College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danah Mansour","family":"Al Mutib","sequence":"additional","affiliation":[{"name":"College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remas Dhafer A.","family":"Al Mohammed","sequence":"additional","affiliation":[{"name":"College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Safar","family":"Alshahrani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mshari Mohammad M.","family":"Al-Asmari","sequence":"additional","affiliation":[{"name":"College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser Saad","family":"AlFawaz","sequence":"additional","affiliation":[{"name":"College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad Mobark","family":"Al Thamr","sequence":"additional","affiliation":[{"name":"College of Medicine, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman Mohammed Abdulhadi","family":"Alamri","sequence":"additional","affiliation":[{"name":"Ophthalmology, King Khalid University, Abha, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"R1-20260619","doi-asserted-by":"crossref","first-page":"644","DOI":"10.18502\/jovr.v16i4.9755","article-title":"Prevalence rates and risk factors for primary open angle glaucoma in the Middle East","volume":"6","author":"Torabi","year":"2021","journal-title":"J Ophthalmic VisRes"},{"key":"R2-20260619","doi-asserted-by":"crossref","DOI":"10.21608\/mjmr.2023.209587.1393","article-title":"Optical coherence tomography angiography changes of the macula in early primary open angle glaucoma compared to healthy eyes","author":"Wahba","year":"2023","journal-title":"El-Minia J. Med. Res"},{"key":"R3-20260619","doi-asserted-by":"crossref","first-page":"101223","DOI":"10.1016\/j.mam.2023.101223","article-title":"Advances in understanding glaucoma pathogenesis: A multifaceted molecular approach for clinician scientists","volume":"94","author":"Ekici","year":"2023","journal-title":"Mol Aspects Med"},{"key":"R4-20260619","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1527319","article-title":"Challenging glaucoma with emerging therapies: An overview of advancements against the silent thief of sight","volume":"12","author":"Sarkis","year":"2025","journal-title":"Front Med"},{"key":"R5-20260619","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/2040622313511286","article-title":"Glaucoma management: Relative value and place in therapy of available drug treatments","volume":"5","author":"Sambhara","year":"2013","journal-title":"Ther Adv Chronic Di"},{"key":"R6-20260619","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/IIO.0000000000000479","article-title":"Minimally invasive glaucoma surgery","volume":"63","author":"Afflitto","year":"2023","journal-title":"Int Ophthalmol Clin"},{"key":"R7-20260619","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/bjo.2009.176024","article-title":"Effect of primary selective laser trabeculoplasty on tonographic outflow facility: A randomised clinical trial","volume":"94","author":"Goyal","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R8-20260619","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1755-3768.2009.01595.x","article-title":"Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma","volume":"88","author":"Mart\u00ednez","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"R9-20260619","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.ophtha.2010.02.016","article-title":"The effect of trabeculectomy on intraocular pressure of the untreated fellow eye in the collaborative initial glaucoma treatment study","volume":"117","author":"Radcliffe","year":"2010","journal-title":"Ophthalmology"},{"key":"R10-20260619","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1755-3768.2009.01604.x","article-title":"Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: The addition of dorzolamide to timolol monotherapy","volume":"88","author":"Siesky","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"R11-20260619","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1755-3768.2009.01852.x","article-title":"Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial","volume":"89","author":"Heijl","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R12-20260619","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.ophtha.2011.01.047","article-title":"Intraocular pressure control and long-term visual field loss in the collaborative Initial Glaucoma Treatment study","volume":"118","author":"Musch","year":"2011","journal-title":"Ophthalmology"},{"key":"R13-20260619","doi-asserted-by":"crossref","first-page":"661670","DOI":"10.1007\/s12325-011-0043-z","article-title":"Travoprost 0.004%\/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%\/timolol 0.5%","volume":"28","author":"Scherzer","year":"2011","journal-title":"Adv Ther"},{"key":"R14-20260619","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/eye.2012.13","article-title":"Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient: A prospective, randomised study","volume":"26","author":"Dahan","year":"2012","journal-title":"Eye"},{"key":"R15-20260619","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s12325-013-0014-7","article-title":"Ocular Surface Tolerability of Prostaglandin Analogs and Prostamides in Patients with Glaucoma or Ocular Hypertension","volume":"30","author":"Crichton","year":"2013","journal-title":"Adv Ther"},{"key":"R16-20260619","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/jop.2012.0235","article-title":"Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%\/brimonidine 0.2%","volume":"29","author":"Nguyen","year":"2013","journal-title":"J Ocular Pharmacol Ther"},{"key":"R17-20260619","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4103\/0301-4738.109520","article-title":"Comparison of outcomes of trabeculectomy with mitomycin C vs. Ologen implant in primary glaucoma","volume":"61","author":"Senthil","year":"2013","journal-title":"Indian J Ophthalmol"},{"key":"R18-20260619","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajo.2012.10.017","article-title":"Risk of endophthalmitis and other long-term complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS)","volume":"155","author":"Zahid","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R19-20260619","first-page":"e133","article-title":"In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma","volume":"92","author":"Frezzotti","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"R20-20260619","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajo.2014.04.003","article-title":"Visual field improvement in the collaborative initial glaucoma treatment study","volume":"158","author":"Musch","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R21-20260619","first-page":"2313","article-title":"Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication","volume":"9","author":"Katz","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"R22-20260619","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/IJG.0000000000000194","article-title":"Efficacy of adjunctive subconjunctival bevacizumab on the outcomes of primary trabeculectomy with mitomycin C","volume":"24","author":"Kiddee","year":"2014","journal-title":"J Glaucoma"},{"key":"R23-20260619","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13063-015-0924-6","article-title":"Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): Study protocol for a randomised controlled trial","volume":"16","author":"Lamoureux","year":"2015","journal-title":"Trials"},{"key":"R24-20260619","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/aos.12722","article-title":"Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: A prospective randomized clinical trial","volume":"93","author":"Matlach","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R25-20260619","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12886-016-0198-0","article-title":"Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: Five-year follow-up","volume":"16","author":"Cillino","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"R26-20260619","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/eye.2016.126","article-title":"Ocular hypotensive effect of fixed-combination brinzolamide\/brimonidine adjunctive to a prostaglandin analog: A randomized clinical trial","volume":"30","author":"Fechtner","year":"2016","journal-title":"Eye"},{"key":"R27-20260619","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ajo.2016.02.026","article-title":"A randomized trial of Fixed-Dose combination brinzolamide 1%\/Brimonidine 0.2% as adjunctive therapy to Travoprost 0.004%","volume":"165","author":"Feldman","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R28-20260619","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40123-016-0065-3","article-title":"Newly diagnosed primary Open-Angle glaucoma randomized to 2 trabecular bypass stents or prostaglandin: Outcomes through 36 months","volume":"5","author":"Vold","year":"2016","journal-title":"Ophthalmol Ther"},{"key":"R29-20260619","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1111\/aos.13401","article-title":"Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients","volume":"95","author":"Aihara","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"R30-20260619","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ophtha.2016.12.027","article-title":"Prophylactic effect of oral acetazolamide against intraocular pressure elevation after cataract surgery in eyes with glaucoma","volume":"124","author":"Hayashi","year":"2017","journal-title":"Ophthalmology"},{"key":"R31-20260619","doi-asserted-by":"crossref","first-page":"e6047","DOI":"10.1097\/MD.0000000000006047","article-title":"The effects of selective laser trabeculoplasty and travoprost on circadian intraocular pressure fluctuations","volume":"96","author":"Kiddee","year":"2017","journal-title":"Medicine"},{"key":"R32-20260619","first-page":"e361","article-title":"Comparing pattern scanning laser trabeculoplasty to selective laser trabeculoplasty: A randomized controlled trial","volume":"95","author":"Mansouri","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"R33-20260619","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajo.2017.09.022","article-title":"West Indies glaucoma laser study (WIGLS): 1. 12-month efficacy of selective laser trabeculoplasty in Afro-Caribbeans with glaucoma","volume":"184","author":"Realini","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R34-20260619","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4103\/ijo.IJO_162_17","article-title":"Viscoelastic-augmented trabeculectomy: A newer concept","volume":"65","author":"Solanki","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R35-20260619","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4103\/ijo.IJO_447_17","article-title":"Simultaneous use of amniotic membrane and mitomycin C in trabeculectomy for primary glaucoma","volume":"65","author":"Yadava","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R36-20260619","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1038\/s41598-018-34627-w","article-title":"Randomised clinical trial for postoperative complications after Ex-PRESS implantation versus trabeculectomy with 2-year follow-up","volume":"8","author":"Arimura","year":"2018","journal-title":"Sci Rep"},{"key":"R37-20260619","doi-asserted-by":"crossref","first-page":"557566","DOI":"10.1111\/aos.13791","article-title":"The glaucoma intensive treatment study (GITS), a randomized clinical trial: Design, methodology and baseline data","volume":"96","author":"Bengtsson","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R38-20260619","first-page":"e577","article-title":"Selective laser trabeculoplasty as replacement therapy in medically controlled glaucoma patients","volume":"96","author":"De Keyser","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"R39-20260619","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2018.01.031","article-title":"Performance and safety of a new AB interno gelatin stent in refractory glaucoma at 12 months","volume":"188","author":"Kalenak","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R40-20260619","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ophtha.2017.10.033","article-title":"Personalized prediction of glaucoma progression under different target intraocular pressure levels using filtered forecasting methods","volume":"125","author":"Kazemian","year":"2017","journal-title":"Ophthalmology"},{"key":"R41-20260619","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/aos.13790","article-title":"Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: Results from the glaucoma intensive treatment study","volume":"96","author":"Lind\u00e9n","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R42-20260619","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/IJG.0000000000000831","article-title":"Latanoprostene Bunod 0.024% in subjects with open-angle glaucoma or ocular hypertension: Pooled phase 3 study findings","volume":"27","author":"Weinreb","year":"2017","journal-title":"J Glaucoma"},{"key":"R43-20260619","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ogla.2019.06.001","article-title":"A first-in-human study of the efficacy and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-I)","volume":"2","author":"Denis","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"R44-20260619","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ogla.2019.03.004","article-title":"Five-year, prospective, randomized, multi-surgeon trial of two trabecular bypass stents versus prostaglandin for newly diagnosed open-angle glaucoma","volume":"2","author":"Fechtner","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"R45-20260619","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.ophtha.2019.04.012","article-title":"Primary selective laser trabeculoplasty for open-angle glaucoma and ocular hypertension","volume":"126","author":"Garg","year":"2019","journal-title":"Ophthalmology"},{"key":"R46-20260619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23310","article-title":"Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: The LiGHT RCT","volume":"23","author":"Gazzard","year":"2019","journal-title":"Health Technol Assess"},{"key":"R47-20260619","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.ophtha.2019.05.032","article-title":"SALT trial: Steroids after laser trabeculoplasty","volume":"126","author":"Groth","year":"2019","journal-title":"Ophthalmol"},{"key":"R48-20260619","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00417-019-04251-z","article-title":"Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma","volume":"257","author":"Reitsamer","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R49-20260619","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/aos.13949","article-title":"Comparison between 90-degree and 360-degree selective laser trabeculoplasty (SLT): A 2-year follow-up","volume":"97","author":"Tawfique","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"R50-20260619","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ogla.2019.03.007","article-title":"Once-daily netarsudil\/latanoprost fixed-dose combination for elevated intraocular pressure in the randomized phase 3 MERCURY-2 study","volume":"2","author":"Walters","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"R51-20260619","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ophtha.2018.10.040","article-title":"24-hour intraocular pressure control with fixed-dose combination brinzolamide 1%\/brimonidine 0.2%","volume":"126","author":"Weinreb","year":"2018","journal-title":"Ophthalmology"},{"key":"R52-20260619","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2020.07.002","article-title":"A randomized controlled trial comparing subconjunctival injection to direct scleral application of mitomycin C in trabeculectomy","volume":"220","author":"Do","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"R53-20260619","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ophtha.2019.10.023","article-title":"Efficacy of repeat selective laser trabeculoplasty in medication-naive open-angle glaucoma and ocular hypertension during the LiGHT trial","volume":"127","author":"Garg","year":"2019","journal-title":"Ophthalmology"},{"key":"R54-20260619","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/aos.14370","article-title":"Can postoperative dexamethasone nanoparticle eye drops replace mitomycin C in trabeculectomy?","volume":"98","author":"J\u00f3hannesson","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R55-20260619","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"R56-20260619","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/s41598-020-80954-2","article-title":"MLIP genotype as a predictor of pharmacological response in primary open-angle glaucoma and ocular hypertension","volume":"11","author":"Canut","year":"2021","journal-title":"Sci Rep"},{"key":"R57-20260619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25720","article-title":"Primary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT","volume":"25","author":"King","year":"2021","journal-title":"Health Technol Assessm"},{"key":"R58-20260619","first-page":"171","article-title":"Efficacy of cyclocryotherapy and transscleral diode laser cyclophotocoagulation in the management of refractory glaucoma","volume":"60","author":"Miljkovi\u0107","year":"2021","journal-title":"Acta Clin Croat"},{"key":"R59-20260619","doi-asserted-by":"crossref","first-page":"e1589","DOI":"10.1016\/S2214-109X(21)00348-X","article-title":"Selective laser trabeculoplasty versus 0\u00b75% timolol eye drops for the treatment of glaucoma in Tanzania: A randomised controlled trial","volume":"9","author":"Philippin","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R60-20260619","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/aos.14576","article-title":"Laser trabeculoplasty in newly diagnosed multi-treated glaucoma patients","volume":"99","author":"Rasmuson","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R61-20260619","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/bjophthalmol-2020-316624","article-title":"12-month randomised trial of 360\u00b0and 180\u00b0Schlemm's canal incisions in suture trabeculotomy ab interno for open-angle glaucoma","volume":"105","author":"Sato","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R62-20260619","doi-asserted-by":"crossref","first-page":"e933454","DOI":"10.12659\/MSM.933454","article-title":"A comparative study of the clinical efficacy and safety of pneumatic trabeculoplasty and selective laser trabeculoplasty for patients with primary open-angle glaucoma or ocular hypertension","volume":"27","author":"Song","year":"2021","journal-title":"Med Sci Monit"},{"key":"R63-20260619","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1120672119878044","article-title":"Brinzolamide\/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma\/ocular hypertension","volume":"31","author":"Topouzis","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"R64-20260619","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12886-021-01818-5","article-title":"Phaco-UCP;Combined phacoemulsification and ultrasound ciliary plasty versus phacoemulsification alone for management of coexisting cataract and open angle glaucoma: A randomized clinical trial","volume":"21","author":"Torky","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"R65-20260619","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajo.2021.04.020","article-title":"Laser in glaucoma and ocular hypertension trial (LIGHT) in China \u2013 A randomized controlled trial: Design and baseline characteristics","volume":"230","author":"Yang","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R66-20260619","first-page":"e455","article-title":"The glaucoma intensive treatment study: Interim results from an ongoing longitudinal randomized clinical trial","volume":"100","author":"Bengtsson","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R67-20260619","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1038\/s41598-023-48121-5","article-title":"Randomised clinical trial for morphological changes of trabecular meshwork between Kahook dual-blade goniotomy and ab interno trabeculotomy with a microhook","volume":"13","author":"Arimura","year":"2023","journal-title":"Sci Rep"},{"key":"R68-20260619","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/bjophthalmol-2021-319379","article-title":"Direct selective laser trabeculoplasty in open angle glaucoma study design: A multicentre, randomised, controlled, investigator-masked trial (GLAUrious)","volume":"107","author":"Congdon","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R69-20260619","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in glaucoma and ocular hypertension (LIGHT) trial","volume":"130","author":"Gazzard","year":"2022","journal-title":"Ophthalmology"},{"key":"R70-20260619","doi-asserted-by":"crossref","first-page":"198199","DOI":"10.1016\/j.ajo.2023.08.021","article-title":"Response to comment on: Long-term impact of immediate versus delayed treatment of early glaucoma: Results from the early manifest glaucoma trial","volume":"256","author":"Heijl","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R71-20260619","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1007\/s12325-023-02589-9","article-title":"Randomized multicenter clinical trial comparing 0.1% brimonidine\/0.5% timolol versus 1% dorzolamide\/0.5% timolol as adjuncts to prostaglandin analogues: AIBeta Crossover study","volume":"40","author":"Inatani","year":"2023","journal-title":"Adv Ther"},{"key":"R72-20260619","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajo.2022.09.011","article-title":"Two-year visual field outcomes of the treatment of advanced glaucoma study (TAGS)","volume":"246","author":"Montesano","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R73-20260619","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/03007995.2023.2197496","article-title":"A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension","volume":"39","author":"Mrukwa-Kominek","year":"2023","journal-title":"Curr Med Res Opinion"},{"key":"R74-20260619","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ogla.2023.03.004","article-title":"Comparing the effectiveness of phacoemulsification+endoscopic cyclophotocoagulation laser versus phacoemulsification alone for the treatment of primary open angle glaucoma in patients with cataract (CONCEPT)","volume":"6","author":"Sherman","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"R75-20260619","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajo.2023.03.026","article-title":"Gel stent versus trabeculectomy: The randomized, multicenter, gold-standard pathway study (GPS) of effectiveness and safety at 12 months","volume":"252","author":"Sheybani","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"R76-20260619","doi-asserted-by":"crossref","first-page":"12179","DOI":"10.1038\/s41598-023-38550-7","article-title":"24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Na\u00efve primary open-angle glaucoma and ocular hypertension patients","volume":"13","author":"Shi","year":"2023","journal-title":"Sci Rep"},{"key":"R77-20260619","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1159\/000531424","article-title":"Comparison between surgical techniques used for revision of the filter bleb: A randomized controlled clinical trial","volume":"66","author":"Zantut","year":"2023","journal-title":"Ophthalmic Res"},{"key":"R78-20260619","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/j.jcrs.0000000000001365","article-title":"Corneal endothelial safety profile in minimally invasive glaucoma surgery","volume":"50","author":"Ahmed","year":"2023","journal-title":"J Cataract Refract Surg"},{"key":"R79-20260619","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ajo.2024.06.017","article-title":"The glaucoma intensive treatment study (GITS): A randomized controlled trial comparing intensive and standard treatment on 5 years visual field development","volume":"266","author":"Bengtsson","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"R80-20260619","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ogla.2023.10.004","article-title":"Optimal performance of selective laser trabeculoplasty","volume":"7","author":"Dahlgren","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"R81-20260619","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ogla.2024.02.004","article-title":"Prospective, randomized controlled trial of cataract surgery vs combined cataract surgery with insertion of iStent inject","volume":"7","author":"Gaskin","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"key":"R82-20260619","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ophtha.2024.01.007","article-title":"Evaluating primary treatment for people with advanced glaucoma","volume":"131","author":"King","year":"2024","journal-title":"Ophthalmology"},{"key":"R83-20260619","doi-asserted-by":"crossref","first-page":"e001449","DOI":"10.1136\/bmjophth-2023-001449","article-title":"Effect of ripasudil after trabeculectomy with mitomycin C: A multicentre, randomised, prospective clinical study","volume":"9","author":"Muhlisah","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"R84-20260619","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ophtha.2023.09.023","article-title":"Ab-Externo MicroShunt versus trabeculectomy in primary open-angle glaucoma","volume":"131","author":"Panarelli","year":"2023","journal-title":"Ophthalmology"},{"key":"R85-20260619","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bjo-2022-321643","article-title":"Differentiating stages of functional vision loss from glaucoma using the disc damage likelihood scale and cup: disc ratio","volume":"108","author":"Philippin","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"R86-20260619","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/IJO.IJO_1340_23","article-title":"Comparison of safety and efficacy of Netarsudil 0.02% and Bimatoprost 0.01% monotherapy and combination therapy in primary open-angle glaucoma and ocular hypertension","volume":"72","author":"Shahid","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"R87-20260619","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/tjo.tjo_63_20","article-title":"Intraocular pressure reduction in glaucoma: Does every mmHg count?","volume":"10","author":"Jayaram","year":"2020","journal-title":"Taiwan J Ophthalmol"},{"key":"R88-20260619","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s40123-022-00539-2","article-title":"CO2 Laser-assisted sclerectomy surgery alone or combined with phacoemulsification in primary open-angle glaucoma: comparison of 1-year outcomes","volume":"11","author":"Chen","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"R89-20260619","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.003","article-title":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition-Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options","volume":"101","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R90-20260619","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/OPTH.S10441","article-title":"Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension","volume":"4","author":"McCluskey","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"R91-20260619","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1111\/jcmm.15172","article-title":"Treatment of glaucoma by prostaglandin agonists and beta-blockers in combination directly reduces pro-fibrotic gene expression in trabecular meshwork","volume":"24","author":"Tejwani","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R92-20260619","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0161-6420(99)90497-9","article-title":"Early manifest glaucoma trial","volume":"106","author":"Leske","year":"1999","journal-title":"Ophthalmology"},{"key":"R93-20260619","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0161-6420(99)90147-1","article-title":"The collaborative initial glaucoma treatment study design, methods, and baseline characteristics of enrolled patients","volume":"106","author":"Musch","year":"1999","journal-title":"Ophthalmology"},{"key":"R94-20260619","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The relationship between control of intraocular pressure and visual field deterioration","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_23_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:31:48Z","timestamp":1787769108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_23_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_23_26","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2026-01-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}